NUBEQA 300 mg Tablets (darolutamide) SmPC Summary
Quick summary NUBEQA 300 mg film-coated tablets contain darolutamide. They are used in specific types of prostate cancer, including non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). This page summarises the...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
NUBEQA 300 mg film-coated tablets contain darolutamide. They are used in specific types of prostate cancer, including non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). This page summarises the main SmPC points in a clear, reader-friendly format.
Medical disclaimer
This article is a summary of product information and is not a substitute for the official SmPC or advice from a qualified healthcare professional. Always check the patient leaflet and speak to a doctor or pharmacist for personal guidance.
What NUBEQA 300 mg tablets are used for
NUBEQA is a prescription medicine used in the treatment of prostate cancer. The active ingredient is darolutamide, which is described as an androgen receptor inhibitor.
According to the source content, NUBEQA is used for:
- Non-metastatic castration-resistant prostate cancer (nmCRPC)
- Metastatic hormone-sensitive prostate cancer (mHSPC)
It is also noted that NUBEQA may be used with docetaxel in some treatment plans.
How NUBEQA works
Darolutamide works by blocking the action of male hormones at the androgen receptor. This helps reduce signals that can support the growth of prostate cancer cells.
The exact place of NUBEQA in treatment depends on the patient’s diagnosis and the wider treatment plan set by the healthcare team.
How NUBEQA is taken
The source content states that the usual total daily dose is 600 mg per day, given as two 300 mg tablets twice daily.
Key administration points mentioned in the content include:
- Take the tablets with food.
- Swallow the tablets whole.
- Do not crush or chew them.
- If a dose is missed, do not double the next dose.
If there is any uncertainty about how the medicine should be taken, the official leaflet or a pharmacist should be consulted.
Side effects mentioned in the source content
Like all medicines, NUBEQA may cause side effects. The current content lists the following:
- Fatigue
- Nausea
- Skin rash
- Diarrhoea
- Changes in liver function tests
The content also notes that liver function monitoring is important.
It additionally mentions that seizures have been reported in rare cases. Anyone with a history of neurological conditions should make sure this is discussed with their healthcare professional.
Precautions and monitoring
The source content highlights several precautions to consider during treatment:
- Monitoring for ischaemic heart disease
- Assessment of liver and renal function
- Checking for possible drug interactions
- Use only as directed for the intended patient group
It also states that NUBEQA should not be used in women or children, and that patients should inform their healthcare team about allergies, other medicines, and relevant medical history.
Important safety points from the source content
The content notes that effective contraception is important for sexually active men whose partners may become pregnant during treatment. It also says patients should discuss any pre-existing conditions and all current medicines with their healthcare provider.
Because treatment decisions are individual, the official SmPC and local prescribing guidance should always be checked for the most up-to-date information.
Price and availability
The price of NUBEQA 300 mg film-coated tablets can vary depending on the country, pharmacy, and insurance coverage. The source content does not give a fixed price.
For accurate cost information, readers should check with a local pharmacy, insurer, or official medicine listing.
Key product details at a glance
| Item | Summary |
|---|---|
| Brand name | NUBEQA |
| Active ingredient | Darolutamide |
| Dosage form | 300 mg film-coated tablets |
| Main uses in the source content | nmCRPC and mHSPC |
| Administration note | Taken with food; swallow whole |
Frequently asked questions
▸ What type of medicine is NUBEQA?
NUBEQA is a prescription medicine containing darolutamide. The source content describes it as an androgen receptor inhibitor used in specific prostate cancer settings.
▸ What conditions is NUBEQA used for?
The content states that it is used for non-metastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer.
▸ Can NUBEQA be taken with food?
Yes. The source content says it should be taken with food.
▸ What side effects are mentioned?
The listed side effects include fatigue, nausea, skin rash, diarrhoea, and changes in liver function tests. Rare seizures are also mentioned.
▸ Who makes NUBEQA?
The source content states that NUBEQA is manufactured by Bayer.
▸ Where should I check the official details?
Readers should check the official SmPC and patient leaflet, or ask a pharmacist or doctor, for the most current and complete information.
Safety reminder: If you are reviewing this medicine for yourself or someone else, use the official product information and speak with a qualified healthcare professional for personalised advice. Do not rely on this summary alone for treatment decisions.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.